نتائج البحث

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia:A Case Report and Prevalence in a Nationwide Population-Based Cohort Study

• Authors : Bhatti, Khazra; Nazir, Aqsa; Ostergaard, Simon

Subjects: article

• Source: Bhatti , K , Nazir , A , Ostergaard , S , Schejbel , L , Norgaard , P , Gjerdrum , L M R , Moghaddas , M , Nielsen , T H , Munksgaard , L & Pedersen , L M 2022 , ' Bone Involvement as a Primary Rare

تفاصيل العنوان

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia:A Case Report and Prevalence in a Nationwide Population-Based Cohort Study

• Authors : Bhatti, Khazra; Nazir, Aqsa; Ostergaard, Simon

Subjects: article

• Source: Bhatti , K , Nazir , A , Ostergaard , S , Schejbel , L , Norgaard , P , Gjerdrum , L M R , Moghaddas , M , Nielsen , T H , Munksgaard , L & Pedersen , L M 2022 , ' Bone Involvement as a Primary Rare

تفاصيل العنوان

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma

• Authors : Berendsen, M.R.; Bladel, D.A.G. van; Hesius, E.A.M.

Subjects: All institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence Pathology; Radboudumc 2: Cancer development and immune defence Tumorimmunology

• Source: Hemasphere, 7, 11

تفاصيل العنوان

Treatment of relapsed and refractory Waldenstrom Macroglobulinemia

• Authors : MS Hematologie; Cancer; Infection & Immunity

تفاصيل العنوان

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.

• Authors : Berendsen, M.R.

Subjects: All institutes and research themes of the Radboud University Medical Center.; Radboudumc 2: Cancer development and immune defence Pathology.; Radboudumc 2: Cancer development and immune defence Tumorimmunology.Article / Letter to editor.

تفاصيل العنوان

ASPEN: Results of a phase 3 randomized trial of zanubrutinib versus ibrutinib for patients with Waldenstrom Macroglobulinemia (WM).

• Authors : Buske C.; Dimopoulos M.; Opat S.

Subjects: Conference Abstract

تفاصيل العنوان

Updated results of the aspen trial from a cohort of patients with wild-type myd88 waldenstrom macroglobulinemia (myd88wt wm).

• Authors : Buske C.; Dimopoulos M.; Garcia Sanz R.

Subjects: Conference Abstract

تفاصيل العنوان

ASPEN: Long-term follow-up results of a phase 3 randomized trial of zanubrutinib (ZANU) versus ibrutinib (IBR) in patients with Waldenstrom macroglobulinemia (WM).

• Authors : Tam C.S.L.; Garcia-Sanz R.; Opat S.

Subjects: Conference Abstract

تفاصيل العنوان

Aspen: long-term follow-up results of a phase 3 randomized trial of zanubrutinib (zanu) vs ibrutinib (ibr) in patients (pts) with waldenstrom macroglobulinemia (wm).

• Authors : Dimopoulos M.; Opat S.; D'Sa S.

Subjects: Conference Abstract

تفاصيل العنوان

Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type : A Swedish lymphoma registry study

• Authors : Brandefors, Lena; Sander, Birgitta; Lundqvist, Kristina

Subjects: clinical aspects; epidemiology; lymphoplasmacytic lymphoma

تفاصيل العنوان